Managing Low Blood Pressure: Causes, Symptoms and Treatment Why Low Blood Pressure Matters?  While high blood pressure gets a lot of attention for its risks, low blood pressure, also known as hypotension, can be just as dangerous. When blood pressure drops too low, it can reduce the flow of blood to vital organs, potentially causing dizziness, fainting, and more serious complications....

A Brain-Computer Interface constitutes revolutionary medical technology that creates seamless neural communication bridges between brain activity and external technological apparatus, circumventing traditional neuromuscular transmission pathways. This advanced system harnesses brain signal detection through sophisticated techniques including electroencephalography (EEG) and converts cognitive...

The pharmaceutical landscape is witnessing a shift toward therapies that prioritize both clinical efficacy and patient experience. A compelling example is the launch of TRYVIO in the U.S. and JERAYGO in the European Union—two brand names representing a novel desmopressin-based therapy created by Ferring Pharmaceuticals. This treatment targets nocturia caused by nocturnal polyuria, a...

Managing Low Blood Pressure: Causes, Symptoms and Treatment Why Low Blood Pressure Matters?  While high blood pressure gets a lot of attention for its risks, low blood pressure, also known as hypotension, can be just as dangerous. When blood pressure drops too low, it can reduce the flow of blood to vital organs, potentially causing dizziness, fainting, and more serious complications....

Managing Low Blood Pressure: Causes, Symptoms and Treatment Why Low Blood Pressure Matters?  While high blood pressure gets a lot of attention for its risks, low blood pressure, also known as hypotension, can be just as dangerous. When blood pressure drops too low, it can reduce the flow of blood to vital organs, potentially causing dizziness, fainting, and more serious complications....

Chronic Brain Damage represents a prolonged neurological syndrome characterized by sustained cerebral impairment originating from various pathological mechanisms including head trauma incidents, vascular brain events, infectious disease processes, extended hypoxic conditions, and progressive neurodegenerative pathologies. Distinguishing from acute neurological episodes that develop rapidly...

Before 2022, OPDIVO, developed through collaborative efforts between Ono Pharmaceutical and Bristol Myers Squibb, encountered formidable market challenges within Japan's increasingly competitive oncology landscape. The therapeutic agent experienced significant market decline as KEYTRUDA vs OPDIVO competition reached critical intensity, with medical professionals demonstrating growing preference...